<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137792">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01812681</url>
  </required_header>
  <id_info>
    <org_study_id>B.10.4.İSM.4.06.68.49</org_study_id>
    <secondary_id>B.10.4.İSM.4.06.68.49</secondary_id>
    <nct_id>NCT01812681</nct_id>
  </id_info>
  <brief_title>Cord Blood 25(oh)-Vitamin D Level in Preterm Infants and Associated Morbidities</brief_title>
  <official_title>Is Higher Cord Blood 25(Oh)-Vitamin D Level Preventive For Any Morbidity Including Rds, Pda, Nec, Bpd And Rop In Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Sami Ulus Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr. Sami Ulus Children's Hospital</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Experimental and observational studies have shown that vitamin D deficiency may be
      associated with an increased risk for non-bone diseases and/or abnormal development for the
      other systems of fetus. The aim of this study is to determine the relationship between cord
      blood 25-hydroxyvitamin D (25 (OH) D) concentrations and the subsequent risk of morbidities
      including RDS, PDA, NEC, BPD AND ROP in preterm infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It was shown that vitamin D play important role in the pathogenesis of long term morbidities
      of newborn. Experimental and observational studies have shown that vitamin D deficiency may
      be associated with an increased risk for non-bone diseases and/or abnormal development for
      the other systems of fetus. The aim of this study is to determine the relationship between
      cord blood 25-hydroxyvitamin D (25 (OH) D) concentrations and the subsequent risk of
      morbidities including RDS, PDA, NEC, BPD AND ROP in preterm infants.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Respiratory distress syndrome</measure>
    <time_frame>three days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The association of vitamin D level with respiratory distress syndrome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sepsis</measure>
    <time_frame>four weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Association of vitamin D level with sepsis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Low vitamin D level</arm_group_label>
    <description>The premature infants with low cord blood vitamin D level</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Vitamin D</arm_group_label>
    <description>The premature infants with normal vitamin D level</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Premature infants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infants &lt;32 weeks of gestational age

        Exclusion Criteria:

          -  infants with major congenital abnormality

          -  infants &gt;32 weeks of gestational age
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dilek Dilli, Assoc Prof</last_name>
    <role>Study Director</role>
    <affiliation>Sami Ulus CH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Serdar Beken, MD</last_name>
    <phone>00903123055000</phone>
    <phone_ext>5274</phone_ext>
    <email>serbeken@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sami Ulus CH</name>
      <address>
        <city>Ankara</city>
        <zip>06120</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serdar Beken, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nurdan Fettah, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Grant WB. Vitamin D supplementation of mother and infant could reduce risk of sepsis in premature infants. Early Hum Dev. 2010 Feb;86(2):133. doi: 10.1016/j.earlhumdev.2010.02.003. Epub 2010 Feb 25.</citation>
    <PMID>20188500</PMID>
  </reference>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 14, 2013</lastchanged_date>
  <firstreceived_date>March 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dr. Sami Ulus Children's Hospital</investigator_affiliation>
    <investigator_full_name>Serdar Beken</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>vitamin D, Respiratory distress syndrome, sepsis, preterm</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
